A potential candidate for the FDA Commissioner's job speaks out on providing more transparency in the approval of medicines and removing conflicts of interest.
Steven Nissen Gives Obama an Rx for FDA Reform
Posted by Sarah Rubenstein Wall Street Journal Blog January 20, 2009...Nissen, himself a potential candidate for FDA commish and often viewed as an enemy of Big Pharma, sounds off in favor of a fixed six-year term for the FDA chief to make the agency less susceptible to political pressures.
He also wants reconsideration of the system in which the drug industry funds a lot of the FDA’s budget through user fees: a system criticized by some for giving the industry too much sway over the agency.
Another Nissen call:
Transparency when it comes to those letters the FDA sends when it’s decided on whether or not to approve drugs. Right now, most of the contents of the letters are secret.
“Secrecy is antithetical to both science and good government, but much of what the FDA knows about drugs, it never discloses,” he writes. “The agency must cease to regard clinical-trial data as proprietary and provide access to all available information on safety and efficacy.”
....
Nissen also recommends restricting direct to consumer advertising in new drugs first two years.